. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Abnormalities, Drug-InducedAnti-Bacterial AgentsAnti-Infective Agents/pharmacologyBacterial Infections/drug therapyChemical and Drug Induced Liver InjuryDrug InteractionsDrug Resistance, MicrobialEndocarditis, Bacterial/drug therapyGonorrhea/drug therapyHumansIntestinal Absorption/drug effectsLeprosy/drug therapyMeningococcal Infections/drug therapyMycobacteriumRespiratory Tract Infections/drug therapyRifampin/administration & dosageRifampin/adverse effectsRifampin/metabolismRifampin/therapeutic useRifampin/toxicityThrombocytosis/chemically inducedTuberculosis/drug therapyTuberculosis, Pulmonary/drug therapyUrologic Diseases/drug therapyViruses/drug effects
Substances: See more » Anti-Bacterial AgentsAnti-Infective AgentsRifampin
Year: 1971 PMID: 4949280 DOI: 10.2165/00003495-197101050-00002
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546